Clinical Trials
🇺🇸 FDA Page 29FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 337–348 of 380 articles
Sapience Therapeutics ST316 Shows 47% Response Rate in Phase 2 Colorectal Cancer Trial
Tozorakimab Meets Primary Endpoint in Phase III COPD Trial, Shows Significant Reduction in Exacerbations
Abogen's ABO2203 mRNA Cancer Therapy Shows Promise in First-in-Human B-Cell Lymphoma Trial at AACR 2026
Inhibrx Biosciences to Present Ozekibart (INBRX-109) Clinical Data for Late-Line Colorectal Cancer Treatment
Debiopharm's Lunresertib Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Cancer Treatment
Adcendo ApS Advances ADCE-T02 Antibody-Drug Conjugate to Expansion Phase, ADCE-D01 Receives FDA Orphan Drug Status
FDA Accepts Genentech's Gazyva Application for Systemic Lupus Erythematosus Treatment
FDA Grants Priority Review to PADCEV-Keytruda Combination for Muscle-Invasive Bladder Cancer Treatment
Diversity in Clinical Trials: FDA's New Guidance and Early Impact
FDA Guidelines for Clinical Trial Sites: What You Need to Know
Dubai Science Park Phase I Studies: What You Need to Know
African Medicines Agency Impact: Multi-Regional Clinical Trials First Year Review